Medical Promotional Review Services

Marketing Collateral and promotional material, such as Visual Aids and Leave Behind Literature (LBLs) have been used by pharmaceutical firms for a long time. But with the advent of digital media and Pharma 4.0, we have seen a rise in the combination of physical and digital communication and digital promotion by pharmaceutical firms. DTC (Direct-to-consumer) Pharmaceutical advertising has also seen a large growth, especially in the U.S., where even prescription drug advertising is regulated but not barred.

The primary objective of any promotional material guided towards the public, or a part of it, is to communicate the benefits as well as the shortcomings (if any) of the medicinal product effectively and clearly. Advertising in the pharma industry should be done without obfuscating Regulatory constraints and following the pharmaceutical advertising regulations as mandated by the Regulatory authorities.